Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Good evening to all, New week that begins in calm with Wall street closed because of presidents day and when the US is not there is calm flat in volume but there is new in our charts On a daily basis, you had to follow my AT of last week or I spoke to you every day of crossing or not crossing MM7 and MM20. Today we finally have our non crossing of rightness. Indeed the MM7 is at 0.316 and the MM20 at 0.315. Tomorrow we need a confirmation candle above these two moving averages and if we close up tomorrow a new leg of rise will certainly arrive towards the 0.33 in very short term to break the red SAR. In case of closing tomorrow below the MM7 and the MM20 it will be direction 0.305 to touch the kijun and tenkan. In weekly, new week so the MM7 weekly has just climbed a notch to 0.297. We do not climb more at this time because of our old bubble, I remind you that we reinstated the bollingers but we did not hit the mm7 hebdo which slowly rises 0.297 tonight. To sum it up, small quiet day in the absence of the USA. The results of 09 March are fast approaching so speculation should soon take off. The monthly close of the end of February will have to be carefully monitored. Indeed within one or two months, if we stayed on these levels the mm7 and mm20 will cross and the, I can tell you that the rise will be great, every thing in this time and small news would not do too much wrong In addition to the AT we will talk about several things: - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few yearswww.actionnaires-pharming-group.sitew... Good night Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
Good evening to all, New day, with the US open and it changes the deal in volume. Indeed slight restart of the volume with traders to the controls that have played with the supports and short-term resistances. Before beginning the AT, a little precision, I do every day the AT for the pleasure because I never make it back to Pharming group. The daily TA is the most difficult on small values ??like our because they deviations are minimal unlike values ??with large volumes. On the other hand the AT weekly and monthly is super reliable when looking at the history of Pharming group and I repeat this year there will be an explosion, not 10 or 20% but much more, but when? On a daily basis, I baked you with my non-crossover MM7 and MM20 that we had yesterday and which is validated today (you must always have a confirmation candle), look at the MM7 (small red dots) deviates from the MM20 (small purple dots) and that's a sign of rising in the short term because the prices refuse to go underneath. We had a slight resistance to 0.326 (+ strong closing of 30/01/2017). So we are caught between the mm7 at 0.32 and the resistance at 0.326 but longer for long. Indeed look at the big red dots (SAR) at 0.328 when they are going to be hit they will go below the quotations and there, the short term rise will arrive. In weekly, the MM7 weekly still at 0.297. We do not climb more at this time because of our old bubble, I remind you that we reinstated the bollingers but we did not hit the mm7 hebdo which slowly rises 0.297 tonight. Next week it will surely come to us or this week so sharp rise, and finally we can launch the new leg of rise above 0.366 To sum up, not crossed confirmed, 0.326 in resistance + sar at 0.328, we are close to the arrival of the new leg of rise. Tonight I give you this post on the incidence of an annual closure above 0.34 I go back for newcomers Why? Look at this annual chart:hpics.li/cedd801 I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but above all we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult to move and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of action of the time nor the valorization. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few yearswww.actionnaires-pharming-group.sitew... Good night Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits) Google Traduction pour les entreprises :Google Kit du traducteurGadget TraductionOutil d'aide à l'ex
Good evening, First of all a big thank you to Tradosaure for its registration on our site as well as for its AT:tradosaure-trading.blogspot.fr/2017/0... New day very calm in volume or nothing has changed. For me, I'm sure traders are working this value, why? At 5.30 pm the price was at 0.319 so under the mm7 day so we broke a support and miracle between 5.30pm and 5.35pm buying 3,000 shares and staying above our mm7. On a daily basis, we are still above the MM7 at 0.319 and the MM20 at 0.316. Small lightweight, we have a resistance to 0.326 (+ strong closing of 30/01/2017). So we are caught between the mm7 at 0.319 and the resistance at 0.326 but longer for a long time. Indeed look at the big red dots (SAR) at 0.325 when they are going to be hit they will go below the prices and there, the short term rise will arrive. Personally I think tomorrow or Friday we will break the SAR, then in the beginning of next week we will touch the MM7 weekly that will finally arrive at us, speculation will begin and the leg of rising long awaited will set up. In weekly, the MM7 weekly still at 0.297. We do not climb more at this time because of our old bubble, I remind you that we reinstated the bollingers but we did not hit the mm7 hebdo which slowly rises 0.297 tonight. Next week it will surely come to us or this week so sharp rise, and finally we can launch the new leg of rise above 0.366 To summarize, support "saved" in the last few seconds, SAR about to be broken, mm7 hebdo arrives slowly but surely and a wave of rising 20 to 30% soon to go higher than the latest highs at 0.366 . I go back for newcomers the annual AT. Why? Look at this annual chart:hpics.li/cedd801 I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but above all we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult to move and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of action of the time nor the valorization. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few yearswww.actionnaires-pharming-group.sitew... Good night Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
Hello, Here is the video of pharming group made by a great French graphic analyst. Have a good daytradosaure-trading.blogspot.fr/2017/0...
De rien Marlanki. Bonne soirée
Good evening, First of all do not hesitate to read this article or Pharming group is quoted in China:cen.acs.org/articles/95/web/2017/02/H... New day very calm in volume with a break of a small support but nothing serious I will tell you right away. On a daily basis, we just broke the MM7 at 0.32 to stagnate above the MM20 at 0.316. At the moment no impact because volumes are very very low. Tomorrow the MM7 at 0.32 will be a resistance and the MM20 at 0.316 a support. I do the AT every day just for the pleasure and for the familiarization for you of the technical analysis but on values ??like these, we really have to place ourselves in relation to the weekly and especially the monthly. Soon we will break the SAR at 0.325 (small red dots) that goes down every day and it will be a bullish signal. Still our resistance at 0.326 (highest closing in recent months). When it is closed, we will certainly attack the 0.366 which are the highest in recent months (but not in the closing). Also look at the bollingers on my drawing, these are the ends of the violet part, they tighten and by experience it will fart soon in one direction or the other. In weekly, the MM7 weekly still at 0.297. We do not climb more at this time because of our old bubble, I remind you that we reinstated the bollingers but we did not hit the mm7 hebdo which slowly rises 0.297 tonight. Next week it will surely come to us or this week so sharp rise, and finally we can launch the new leg of rise above 0.366 To summarize tonight, we broke a small support the MM7 at 0.32 but nothing serious all the long-term supports are well underneath as well as the majority of short-term media. We stagnate quietly while waiting for the MM7 weekly because of this old bubble. For me, in the next few weeks we will make a higher than the 0.366 certainly towards the 0.43 cloud ichimoku monthlywww.actionnaires-pharming-group.sitew... I go back for newcomers the annual AT. Why? Look at this annual chart:hpics.li/cedd801 I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but above all we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult to move and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of action of the time nor the valorization. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few years Good night Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
De posts van dit forumlid, overtreft m.i. alle posts op dit forum. Bedankt voor deze waardevolle bijdragen !
Good evening, First of all, it is the weekend, if some want to start in AT here is the free ebook of Tradosaure for the novices, I started the AT with him and with this ebook:blogspot.us7.list-manage.com/subscrib... New day very calm in volume with a break of new short-term supports, I will tell you right away. On a daily basis, we broke the mm7 yesterday which has now become a small resistance at 0.318. Today we just broke the tenkan at 0.318 and the mm20 at 0.316, thanks to the kijun which supported us at 0.308. Look, we are now in a triangle that blocked us today, the high part of Monday will be 0.317 and the low part 0.301. The exit is scheduled for March 03 at the latest, if output from the top, short-term rise, if output by the lower short-term decline. At the moment no impact because volumes are very very low. I do the AT every day just for the pleasure and for the familiarization for you of the technical analysis but on values ??like these, we really have to place ourselves in relation to the weekly and especially the monthly. Soon we will break the SAR at 0.323 (small red dots) that goes down every day and it will be a bullish signal. Still our resistance at 0.326 (highest closing in recent months). When it is closed, we will certainly attack the 0.366 which are the highest in recent months (but not in the closing). Also look at the bollingers on my drawing, these are the ends of the violet part, they tighten and by experience it will fart soon in one direction or the other. In weekly, we are Friday therefore closing of the weekly. Despite the decline everything goes very well for the medium term. I bind you with it since January, the bubble, the bubble and still the bubble and ben yes it is because of it that we are blocked since January. The MM7 weekly still at 0.297. We do not climb more at this time because of our old bubble, I remind you that we reinstated the bollingers but we did not hit the mm7 hebdo which slowly rises 0.297 tonight. Next week the MM7 weekly will finally arrive to us, wait Monday but I think it will be between 0.30 and 0.31 and at the contact of the courses, we will see if we are ready for the new leg of rise above the 0.366 towards the 0.43 which Corresponds to the monthly cloud. To summarize tonight, we broke two new short-term media, we are now in a triangle whose release will arrive before 03 March. Nothing serious all long-term supports are well underneath as well as the majority of short-term media. I will use the word serious if we close a Friday under the weekly cloud at 0.277. We stagnate quietly while waiting for the MM7 weekly because of this old bubble. For me, in the next few weeks we will make a higher than the 0.366 certainly towards the 0.43 monthly ichimoku cloud. Also watch out, on Tuesday, Feb. 28, the last day of the month is fast approaching, traders will take orders from the stock market Monday and Tuesday to create the candle that interests them. Here is the daily and weekly chart below:www.actionnaires-pharming-group.sitew... In addition to the TA we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few years I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why? Look at this annual chart:hpics.li/770e224 I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult to move and often it takes 2 to 10 years to achieve them. The last
With pleasure Kippekop. Good evening, do not hesitate to register with us: Www.actionnaires-pharming-group.sitew.fr
This is my AT, after being dazzled by my day at the Carnival of Venice: Good evening, New week begins with a great news for the future evolution of pharming group courses, the weekly bubble is treated. On a daily basis, we are still in a triangle with an exit at the latest on March 03, if output by the high beautiful rise, if output by the bottom nasty drop. For tomorrow the high point of the triangle will be at 0.315 and the low point at 0.303. Still very little volume, we are under the mm20 at 0.314, the kjun at 0316, the mm7 at 0.317, the tenkan at 0.318 and the sar at 0.32. When we recross her little resistances, the beautiful will leave again. I do the AT every day just for the pleasure and for the familiarization for you of the technical analysis but on values ??like these, we really have to place ourselves in relation to the weekly and especially the monthly. Soon we will break the SAR at 0.32 (small red dots) that goes down every day and it will be a bullish signal. Still our resistance at 0.326 (highest closing in recent months). When it is closed, we will certainly attack the 0.366 which are the highest in recent months (but not in the closing). Also look at the bollingers on my drawing, these are the ends of the violet part, they tighten and by experience it will fart soon in one direction or the other. In weekly, alleluia, youpi, we have finally treated our bubble after 4 weeks of stagnation. Because of it we were stuck, and lost time but not serious, look at the drawing, the candle of the day touched the small dots down which represents the MM7 weekly. Now this weekly MM7 is a big support and should soon propel Pharminh above the latest highs at 0.366, I think about the 0.43. But the rise will be triggered by what? Great results on March 09? Speculation before results? A news? To summarize the daily short-term is not famous but with the weakness of volumes down no worries to have. Finally our weekly bubble is treated. For me, in the next few weeks we will make a higher than the 0.366 certainly towards the 0.43 monthly ichimoku cloud. Also watch out, on Tuesday, Feb. 28, the last day of the month is fast approaching, traders will take orders from the stock market Tuesday to create the candle that interests them. Here is the daily and weekly chart below:www.actionnaires-pharming-group.sitew... In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few years I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why? Look at this annual chart:www.noelshack.com/2017-09-1488218378-... I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there Good night Finally I specify that I own 500,000 shares, that I do not give advice to buy or sell Google Traduction pour les entreprises :Google Kit du traducteurGadget TraductionOutil d'aide à l'export
Thanks for your TA and clear explonation.
kippekop schreef op 27 februari 2017 20:27 :
Thanks for your TA and clear explonation.
explanation. :-)
Haha, ja dat is een samenvatting van uitleg en explosie.
kippekop schreef op 27 februari 2017 20:37 :
Haha, ja dat is een samenvatting van uitleg en explosie.
Kuku en kip,gezellig stel.
Here is my AT a little late because of Carnival in Venice, to see for those who do not know, it is unique in the world. Good evening, Last day of the month with little volume, waiting for an early departure. Tomorrow night, do not miss my AT, I will do a monthly special with the new March chart and I will show you in drawing why the monthly MM7 and MM20 cross monthly will lead to very high Pharming group in the coming months if it takes place around March -April. On a daily basis, we are still in a triangle with an exit at the latest on March 03, if output by the high beautiful rise, if output by the bottom nasty drop. Watch today how the top of the triangle has blocked us. For tomorrow the high point of the triangle will be at 0.313 and the low point at 0.304. Still very little volume, we are under the mm20 at 0.314, the mm7 at 0316, the mm7 at 0.317, the tenkan at 0.318, sar at 0.319 and the kijun at 032.3. When we recross her little resistances, the beautiful will leave again. I do the AT every day just for the pleasure and for the familiarization for you of the technical analysis but on values ??like these, you really have to place yourself in relation to the weekly and especially the monthly. Soon we will break the SAR at 0.319 (small red dots) that goes down every day and it will be a bullish signal. Still our resistance at 0.326 (highest closing in recent months). When it is closed, we will certainly attack the 0.366 which are the highest in recent months (but not in the closing). Also look at the bollingers on my drawing, these are the ends of the violet part, they tighten and by experience it will fart soon in one direction or the other. In weekly, now this MM7 weekly is a big support and should soon propel Pharming group like a trampoline above the last highest to 0.366, I think about the 0.43. The rise can not resume until the volume returns. But the rise will be triggered by what? Great results on March 09? Speculation before results? A news? To summarize before March 03, the daily triangle will be broken and depending on the meaning of big break break or nasty drop. I also want to confirm that all the medium and long term media are intact, do not miss tomorrow night's TA or I will explain why a big one will happen very quickly. Here is the daily and weekly chart below:www.actionnaires-pharming-group.sitew... In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back - Do not forget what I repeat for March-April 2017, a rare crossing mm7 and mm20 could take place which would lead to an increase of several months to a few years I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why? Look at this annual chart:www.noelshack.com/2017-09-1488218378-... I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there Good night Finally I specify that I own 500,000 shares
Annual technical analysis of March 01, 2017, 9 months in advance. Above all, I am a shareholder in Pharming group with 500,000 shares in the portfolio. As promised, I reveal the reasons for my continued optimism on Pharming group. I'm not a magician, I'm not seeing, just I've been studying over 100 graphics a day for years and I've found a nearly foolproof method to invest in long-term value. Here is my method. Annual technical analysis: An annual technical analysis allows investing on a value for a few years without worrying about temporary stock movements during a year, you buy at a T time and you sell when you have made a maximum of appreciation. But what is this moment? Above all, for those who do not know the TA, only the closing on 31/12 therefore counts not to buy or sell too soon. What is this moment T? The moment T is the passage from the moving average to 7 years called MM7. When she passed, it rarely happens about every 3 to 10 years depending on the values, an explosion of courses is observed for a few years with courses multiplied by 2-3-30, look at Genfit and other examples below? So to sum up, you want to earn a lot of money without looking at your screen all day, adopt this technique. Click on each link below and you will easily understand that when the candle exceeds the small dots (MM7 annually) the courses soar.www.noelshack.com/2017-09-1488371462-... www.noelshack.com/2017-09-1488371461-... www.noelshack.com/2017-09-1488371462-... www.noelshack.com/2017-09-1488371462-... Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34. To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take him to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....www.noelshack.com/2017-09-1488371561-... Good evening and good reading
Monthly technical analysis of March 01, 2017. Above all, I am a shareholder in Pharming group with 500,000 shares in the portfolio. As promised, I reveal the reasons for my optimism on Pharming group. Optimism multiplied by 100 since today but why? Here are the reasons: Monthly technical analysis: A monthly technical analysis allows investing on a value for a few months to 1 or two years without worrying about temporary stock market movements during the stock market you buy at a time T and you sell when you have made a maximum of appreciation . But what is this moment? First of all, for those who do not know the TA, only the closing at the end of the month therefore takes care not to buy or sell too soon. What is this moment T? Time T is the cross between the 7-month moving average (MM7) and the 20-month moving average (MM20). This figure happens quite rarely and when this happens there is an explosion of prices after this crossing. Look at examples of values ??other than Pharming group:www.noelshack.com/2017-09-1488372237-... www.noelshack.com/2017-09-1488372237-... www.noelshack.com/2017-09-1488372237-... www.noelshack.com/2017-09-1488372237-... www.noelshack.com/2017-09-1488372237-... www.noelshack.com/2017-09-1488372239-... Why so much trust for Pharming? It is simple the crossing took place this morning in this beautiful first day of March, the MM7 monthly crossed the MM20 monthly. Look it's beautiful:www.noelshack.com/2017-09-1488387109-... The last time it happened, in January 2014 we went from 0.14 to 0.72, look at:www.noelshack.com/2017-09-1488372238-... To summarize the crossing has just taken place, do not ask me when the rise will happen, I do not know, it can be tomorrow, in 1 month or this summer. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take it to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA .... Good evening and good reading
Good evening, Before you start read my AT monthly and yearly and you will understand my optimism. On a daily basis, we are still in a triangle with an exit at the latest on March 03, if output by the high beautiful rise, if output by the bottom nasty drop. Watch today how the top of the triangle has blocked us. For tomorrow the high point of the triangle will be at 0.311 and the low point at 0.306. Still very little volume, we are under the mm20 at 0.314, the mm7 at 0314, the mm7 at 0.315, the tenkan at 0.316, sar at 0.316. Good news the kijun is ironed below at 0.309. When we recross her little resistances, the beautiful will leave again. I do the AT every day just for the pleasure and for the familiarization for you of the technical analysis but on values ??like these, you really have to place yourself in relation to the weekly and especially the monthly. Soon we will break the SAR at 0.316 (small red dots) that goes down every day and it will be a bullish signal. Still our resistance at 0.326 (highest closing in recent months). When it is closed, we will certainly attack the 0.366 which are the highest in recent months (but not in the closing). Also look at the bollingers on my drawing, these are the ends of the violet part, they tighten and by experience it will fart soon in one direction or the other. In weekly, now this MM7 weekly is a big support and should soon propel Pharming group like a trampoline above the last highest to 0.366, I think about the 0.43. The rise can not resume until the volume returns. But the rise will be triggered by what? Great results on March 09? Speculation before results? A news? To summarize before March 03, the daily triangle will be broken and depending on the meaning of big break break or nasty drop. When I say increase or decrease, it is in daily therefore less important than on large units. I would also like to confirm that all medium and long term media are intact. Here is the daily and weekly chart below:www.actionnaires-pharming-group.sitew... In addition to the AT we will talk about several things (I put it every day for new ones): - Results 2016 March 09 at 7 o'clock so speculation should start, for my part nothing to wait because we were under the influence of Valéant on the other hand if Devries talks about the turnover of the first quarter that will be announced in May, Could explode. - Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back -a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why? Look at this annual chart:www.noelshack.com/2017-09-1488218378-... I had forgotten to look at the annual AT because it is a very very long term AT and there is something very important to say. The annual MM7 is at 0.346 and we are underneath since 2007 if we cross it and we remain above the end of 2017 we will certainly be richer than now but mostly we will witness a change of era of several years on PHARM. Let me explain, the annual resistance is very difficult and often it takes 2 to 10 years to achieve them. The last time we passed the MM7 annual it was in 2005, the price had risen from 3.3 € in 2003 to 43.1 in 2006 to be multiplied by about 15. For detractors, I did not know the number of shares of the time nor the valuation. But all this to show that the crossing of 0.3386, if it takes place, will take us elsewhere, far, high .... To show the reverse mechanism in 2007 we moved back below, the highest of the year was 43.1 and the lowest 8 euros, followed by a 10-year drop taking it to the bottom of the hole close to 0 and Since we are there Good night Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)